World Journal of Hepatology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Antoury C, Lopez R, Zein N, Stoller JK, Alkhouri N. Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease. World J Hepatol 2015; 7(10): 1427-1432 [PMID: 26052388 DOI: 10.4254/wjh.v7.i10.1427]
URL:	https://www.wjgnet.com/1948-5182/full/v7/i10/1427.htm

(386) (313) (0) (0) (0) (6514) (43)

Number	Citing Articles
1	Joshua P Kronenfeld, Neha Goel. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S284430
2	Carolin Victoria Schneider, Marie Decraecker, Aurélie Beaufrère, Audrey Payancé, Audrey Coilly, Kai Markus Schneider, Paulette Bioulac, Jean-Frédéric Blanc, Brigitte Le Bail, Samuel Amintas, Marion Bouchecareilh. Alpha-1 antitrypsin deficiency and primary liver cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(2) doi: 10.1016/j.bbcan.2025.189290
3	Kaitlyn Carlson, Abbey Barnard Giustini. Editorial: Understanding the Role of the Alpha‐1 PiMZ Genotype in the Development of Hepatocellular Carcinoma for Patients With ACLD. Alimentary Pharmacology & Therapeutics* 2026; 63(10) doi: 10.1111/apt.70548
4	Olivier Guillaud, Jérôme Dumortier, Eduardo Couchonnal-Bedoya, Mathias Ruiz. Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests. Diagnostics 2023; 13(2) doi: 10.3390/diagnostics13020256
5	Yanping Zhao, Lei Ye, Yaping Yu. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6) doi: 10.1016/j.clinre.2020.03.025
6	El-Gaily A. El-Rayah, Patrick J. Twomey, Eleanor M. Wallace, Peter A. McCormick. Both α-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland. European Journal of Gastroenterology & Hepatology 2018; 30(4) doi: 10.1097/MEG.0000000000001056
7	Reto Eggenschwiler, Mohsen Moslem, Mariane Serra Fráguas, Melanie Galla, Oliver Papp, Maximilian Naujock, Ines Fonfara, Ingrid Gensch, Annabell Wähner, Abbas Beh-Pajooh, Claudio Mussolino, Marcel Tauscher, Doris Steinemann, Florian Wegner, Susanne Petri, Axel Schambach, Emmanuelle Charpentier, Toni Cathomen, Tobias Cantz. Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase. Scientific Reports 2016; 6(1) doi: 10.1038/srep38198
8	Lincoln J Pac, Gregory Cheeney, Maria Westerhoff, Eric Q Konnick, Dina N Greene, Christina M Lockwood. Real-Time PCR to Detect α-1 Antitrypsin S and Z Alleles in Formalin-Fixed Paraffin-Embedded Tissue. The Journal of Applied Laboratory Medicine 2018; 3(1) doi: 10.1373/jalm.2017.025858
9	Virginia C. Clark. Liver Transplantation in Alpha-1 Antitrypsin Deficiency. Clinics in Liver Disease 2017; 21(2) doi: 10.1016/j.cld.2016.12.008
10	Islam Rajab, Monica Pernia Marin, Abdalhakim Shubietah, Ayman Khaled, Mohammad Bdair, Maram M. Abukhalil, Hammam Jallad, Abdallah Hussein, Samia Ammar Aldwaik, Mary M. Salvatore. Alpha-1 antitrypsin deficiency: genetics, clinical manifestations, AI prognostics, and advanced imaging in liver disease. Annals of Medicine & Surgery 2025; 87(11) doi: 10.1097/MS9.0000000000003913
11	Olivier Guillaud, Jérôme Dumortier, Julie Traclet, Lioara Restier, Philippe Joly, Colette Chapuis-Cellier, Alain Lachaux, Jean François Mornex. Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency. Clinics and Research in Hepatology and Gastroenterology 2019; 43(1) doi: 10.1016/j.clinre.2018.08.016
12	Alberto Quaglia, Eve A. Roberts, Michael Torbenson. Macsween's Pathology of the Liver. 2018; doi: 10.1016/B978-0-7020-6697-9.00003-0
13	Muhammad Masroor Hussain, Bi Feng, Ju‐Mei Wang, Ao‐Qiang Zhai, Fu‐yu Li, Hai‐jie Hu. Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma. Cancer Medicine 2025; 14(21) doi: 10.1002/cam4.71330
14	Pavel Strnad, Carolin V. Schneider, Virginia Clark. α1-Antitrypsin Deficiency. 2019; doi: 10.1183/2312508X.10033018
15	Nazli Khodayari, Regina Oshins, Alek M. Aranyos, Sergio Duarte, Sayedamin Mostofizadeh, Yuanqing Lu, Mark Brantly. Characterization of hepatic inflammatory changes in a C57BL/6J mouse model of alpha1-antitrypsin deficiency. American Journal of Physiology-Gastrointestinal and Liver Physiology 2022; 323(6) doi: 10.1152/ajpgi.00207.2022
16	Pasquale Piccolo, Sergio Attanasio, Nicola Brunetti-Pierri. α1-Antitrypsin Deficiency. 2019; doi: 10.1183/2312508X.10032818
17	Jinqi Tu, Bo Wang, Xiaoming Wang, Kugeng Huo, Wanting Hu, Rongli Zhang, Jinyao Li, Shijie Zhu, Qionglin Liang, Shuxin Han. Current status and new directions for hepatocellular carcinoma diagnosis. Liver Research 2024; 8(4) doi: 10.1016/j.livres.2024.12.001
18	Umur Hatipoğlu, James K. Stoller. α1-Antitrypsin Deficiency. Clinics in Chest Medicine 2016; 37(3) doi: 10.1016/j.ccm.2016.04.011
19	Zuzana Rabekova, Sona Frankova, Milan Jirsa, Magdalena Neroldova, Mariia Lunova, Ondrej Fabian, Martin Kveton, David Varys, Klara Chmelova, Vera Adamkova, Jaroslav A. Hubacek, Julius Spicak, Dusan Merta, Jan Sperl. Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910560
20	Mahmoud Aryan, Thomas Ruli, Mohamed Shoreibah. HCC in patients without cirrhosis: A review. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000224
21	Gregory Cheeney, Lincoln J. Pac, Purva Gopal, Charles S. Landis, Eric Q. Konnick, Paul E. Swanson, Dina N. Greene, Christina M. Lockwood, Maria Westerhoff. Increased Frequency of Heterozygous Alpha‐1‐Antitrypsin Deficiency in Liver Explants From Nonalcoholic Steatohepatitis Patients. Liver Transplantation 2020; 26(1) doi: 10.1002/lt.25652
22	Jorge A. Marrero. Surveillance for Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4) doi: 10.1016/j.cld.2020.07.013
23	Carolin V. Schneider, Pavel Strnad. α1-Antitrypsin Deficiency. 2019; doi: 10.1183/2312508X.10013419
24	Alberto Quaglia, Eve A. Roberts, Michael Torbenson. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00003-X
25	Jose Melendez-Rosado, Ali Alsaad, Fernando F. Stancampiano, William C. Palmer. Abnormal Liver Enzymes. Gastroenterology Nursing 2018; 41(6) doi: 10.1097/SGA.0000000000000346
26	Mohamed G Shoreibah, Brendan M McGuire, Omar I Massoud, Meagan E Gray, Ross M Hansen, Patrick S Harris. Hepatocellular carcinoma surveillance: An evidence-based approach. World Journal of Gastroenterology 2019; 25(13): 1550-1559 doi: 10.3748/wjg.v25.i13.1550 Abstract(1651) \| Core Tip(1460) \| Full Article(HTML)(13951) \| Full Article (PDF)-1550K(1694) \| Full Article (Word)-83K(307) \| Audio-570K(46) \| Peer-Review Report-201K(336) \| Answering Reviewers-35K(498) \| Times Cited (177) \| Total Visits (16624) \| Open
27	Romil Saxena, Pierre Russo. Practical Hepatic Pathology: a Diagnostic Approach. 2018; doi: 10.1016/B978-0-323-42873-6.00009-3
28	Malin Fromme, Pavel Strnad. Liver cancer in severe alpha-1 antitrypsin deficiency: who is at risk?. European Respiratory Journal 2022; 60(5) doi: 10.1183/13993003.00718-2022
29	Mehdi Afsharinasab, Amir Hossein Akbari, Vahid Mirzaei, Mehdi Mahmoodi, Mohammad Reza Hajizadeh, Jamal Amri, Alireza Khoshdel. The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis. Hormone Molecular Biology and Clinical Investigation 2022; 43(4) doi: 10.1515/hmbci-2022-0001
30	Nora V. Bergasa. Clinical Cases in Hepatology. 2022; doi: 10.1007/978-1-4471-4715-2_10
31	Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68(2) doi: 10.1002/hep.29913
32	Stefan J. Marciniak, Adriana Ordóñez, Jennifer A. Dickens, Joseph E. Chambers, Vruti Patel, Caia S. Dominicus, Elke Malzer. New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms. Annals of the American Thoracic Society 2016; 13(Supplement_4) doi: 10.1513/AnnalsATS.201506-358KV
33	Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Mark Angelo S. del Rosario, Matthew Aldren S. Ora, Jiayan Zhou, Kin Israel Notarte, Wan‐Chun Li, Ching‐Wen Chang. Genetic variants underlying precancerous conditions of hepatocellular carcinoma. International Journal of Cancer 2026; 158(3) doi: 10.1002/ijc.70092
34	Sanjeev Kumar Verma, Rajeev Khanna. Pediatric hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(35): 3980-3999 doi: 10.3748/wjg.v24.i35.3980 Abstract(1672) \| Core Tip(1423) \| Full Article(HTML)(21346) \| Full Article (PDF)-2938K(2084) \| Audio-383K(31) \| Peer-Review Report-173K(291) \| Answering Reviewers-141K(400) \| Times Cited (145) \| Total Visits (25327) \| Open
35	Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00012-4
36	Lorenz Balcar, Georg Semmler, Bernhard Scheiner, Rafael Paternostro, Benedikt Simbrunner, Tina Jasmin Haunold, Mathias Jachs, Lukas Hartl, Benedikt Silvester Hofer, Nina Dominik, Michael Schwarz, Georg Kramer, Christian Sebesta, Paul Thöne, Matthias Pinter, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer, Mattias Mandorfer. The Alpha‐1 PiMZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD. Alimentary Pharmacology & Therapeutics* 2026; 63(10) doi: 10.1111/apt.70530
37	Fouad Jaber, George Cholankeril, Hashem B El-Serag. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies. Journal of the Canadian Association of Gastroenterology 2024; 7(5) doi: 10.1093/jcag/gwae025
38	Praveena Narayanan, Pramod K. Mistry. Update on Alpha‐1 Antitrypsin Deficiency in Liver Disease. Clinical Liver Disease 2020; 15(6) doi: 10.1002/cld.896
39	Helena Moreira-Silva, João Amorim, Ermelinda Santos-Silva. Incidental Liver Lesions in children: A practical and evidence-based approach. Clinics and Research in Hepatology and Gastroenterology 2022; 46(5) doi: 10.1016/j.clinre.2022.101904
40	Nedim Hadžić. Liver Disease in Adolescence. In Clinical Practice 2022; doi: 10.1007/978-3-030-98808-1_6
41	Jagadeesh Menon, Mukul Vij, Deepti Sachan, Ashwin Rammohan, Naresh Shanmugam, Ilankumaran Kaliamoorthy, Mohamed Rela. Pediatric metabolic liver diseases: Evolving role of liver transplantation. World Journal of Transplantation 2021; 11(6): 161-179 doi: 10.5500/wjt.v11.i6.161 Abstract(1185) \| Core Tip(1154) \| Full Article(HTML)(7551) \| Full Article (PDF)-43991K(999) \| Full Article (Word)-5414K(171) \| Audio-10795K(21) \| Peer-Review Report-201K(271) \| Answering Reviewers-135K(234) \| Times Cited (20) \| Total Visits (10104) \| Open
42	Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S404424
43	Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.001